Lepik K, Mikhailova N, Kondakova E, et al. Nivolumab for treatment of patients with relapsed/refractory classical Hodgkin’s lymphoma (CHL): clinical and patient-reported outcomes. 24th Congress of EHA, abstract PS1239.
Europese goedkeuring pembrolizumab voor behandeling van recidief of refractair klassiek HL
mei 2017 | Lymfoom